Jorden David Emerson: insider trades.
Jorden David Emerson reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 2 open-market purchases ($10K) and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 2
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- JORDEN DAVID EMERSON
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Nuo Therapeutics, Inc. (AURX) | Director, Officer · CEO/CFO | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-28 | Nuo Therapeutics, Inc. | P | 7,984 | $1.09 | 2,070,000 | Form 4/A |
| 2026-08-28 | Nuo Therapeutics, Inc. | A | 7,984 | $1.09 | 2,070,000 | Form 4 |
| 2026-08-27 | Nuo Therapeutics, Inc. | P | 789 | $1.07 | 2,062,016 | Form 4/A |
| 2026-08-27 | Nuo Therapeutics, Inc. | A | 789 | $1.07 | 2,062,016 | Form 4 |
| 2026-06-30 | Nuo Therapeutics, Inc. | F | 160,892 | $1.01 | 2,061,227 | Form 4 |
| 2026-06-30 | Nuo Therapeutics, Inc. | M | 162,500 | $1 | 2,222,119 | Form 4 |
Questions
What stock did Jorden David Emerson buy or sell?
Jorden David Emerson reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 2 open-market purchases ($10K) and 0 sales, across 1 company.
Is Jorden David Emerson the same person as other filers with this name?
This page covers SEC CIK 1313516 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/jorden-david-emerson-1313516.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.